Trade

with

CR Bard Inc
(NYSE: BCR)
AdChoices
157.52
+3.29
+2.13%
After Hours :
-
-
-

Open

155.10

Previous Close

154.23

Volume (Avg)

284.30k (525.60k)

Day's Range

155.10-157.52

52Wk Range

125.00-157.52

Market Cap.

11.51B

Dividend Rate (Yield )

0.88 (0.56%)

Beta

0.73

Shares Outstanding

74.90M

P/E Ratio (EPS)

15.46 (10.65)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 3.05B

    • Net Income

    • 689.80M

    • Market Cap.

    • 11.51B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 24.87

    • PEG (Price/Earnings Growth) Ratio

    • 1.71

    • Beta

    • 0.73

    • Forward P/E

    • 17.73

    • Price/Sales

    • 3.69

    • Price/Book Value

    • 6.31

    • Price/Cash flow

    • 9.91

      • EBITDA

      • 1.40B

      • Return on Capital %

      • 16.90

      • Return on Equity %

      • 48.76

      • Return on Assets %

      • 16.90

      • Book Value/Share

      • 22.47

      • Shares Outstanding

      • 74.90M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.22 (10/16/2014)

      • Dividend Declaration Date

      • 10/8/2014

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 147.00

        • Credit Rating

        • A+

        • Analysts

        • 3

        • EPS Estimate

        • 7.21

        • Cashflow Estimate

        • 10.88

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 8.80

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • 30.10

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 4.46

          • 12.51

          • Net Income

            5-Year Annual Average

          • 10.60

          • 4.16

          • Dividends

            5-Year Annual Average

          • 5.75

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 61.18

            • 52.83

            • Pre-Tax Margin

            • 41.33

            • 15.96

            • Net Profit Margin

            • 24.87

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 61.90

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 27.00

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 17.70

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.84

              • 0.62

              • Current Ratio

              • 2.59

              • 1.97

              • Quick Ratio

              • 1.85

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 3.05

              • 2.38

              • Book Value/Share

              • 22.47

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 14.95

                • 35.97

                • P/E Ratio 5-Year High

                • 15.45

                • 279.76

                • P/E Ratio 5-Year Low

                • 7.42

                • 148.87

                • Price/Sales Ratio

                • 3.72

                • 3.33

                • Price/Book Value

                • 6.64

                • 4.16

                • Price/Cash Flow Ratio

                • 9.91

                • 17.27

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 48.76

                    (26.20)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 16.90

                    (14.10)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 25.90

                    (18.60)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 60.75k

                  • 25.65k

                  • Inventory Turnover

                  • 3.53

                  • 2.66

                  • Asset Turnover

                  • 0.68

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  1.21B
                  Operating Margin
                  39.79
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  9.91
                  Ownership

                  Institutional Ownership

                  92.97%

                  Top 10 Institutions

                  42.34%

                  Mutual Fund Ownership

                  52.11%

                  Float

                  89.52%

                  5% / Insider Ownership

                  1.47%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • AMG Yacktman Fund

                  •  

                    3,250,000

                  • -2.40

                  • 4.34

                  • AMG Yacktman Focused Fund

                  •  

                    2,150,000

                  • -6.52

                  • 2.87

                  • Vanguard Mid-Cap Index Fund

                  •  

                    1,276,833

                  • -1.06

                  • 1.70

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,245,401

                  • 0.43

                  • 1.66

                  • Vanguard Health Care Fund

                  •  

                    1,157,400

                  • -37.07

                  • 1.55

                  • American Century Growth Fund

                  •  

                    1,040,900

                  • 0.00

                  • 1.39

                  • Findlay Park American Fund

                  •  

                    913,350

                  • 9.21

                  • 1.22

                  • Vanguard Five Hundred Index Fund

                  •  

                    774,830

                  • -1.90

                  • 1.03

                  • Principal MidCap Fund

                  •  

                    766,684

                  • 1.50

                  • 1.02

                  • Vanguard Institutional Index Fund

                  •  

                    755,943

                  • -3.17

                  • 1.01

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Yacktman Asset Management Co

                  •  

                    6,701,207

                  • -1.85%

                  • 8.98

                  • Vanguard Group, Inc.

                  •  

                    6,491,857

                  • +1.83%

                  • 8.70

                  • State Street Corp

                  •  

                    3,725,279

                  • +0.18%

                  • 4.99

                  • Walter Scott & Partners Ltd

                  •  

                    3,241,458

                  • -1.53%

                  • 4.34

                  • BlackRock Fund Advisors

                  •  

                    2,356,937

                  • -0.86%

                  • 3.16

                  • Wellington Management Company, LLP

                  •  

                    2,219,793

                  • -25.70%

                  • 2.97

                  • Goldman Sachs Asset Management, L.P.

                  •  

                    1,928,792

                  • -35.59%

                  • 2.58

                  • Northern Trust Investments, N.A.

                  •  

                    1,883,896

                  • -3.70%

                  • 2.52

                  • American Century Inv Mgt, Inc.

                  •  

                    1,785,540

                  • +3.48%

                  • 2.39

                  • Columbia Mangmt Investment Advisers, LLC

                  •  

                    1,277,121

                  • +63.91%

                  • 1.71

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Classic Growth

                  Style

                  Mid Growth

                  CR Bard Inc was incorporated in 1923. The Company engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells a range of products to hospitals, ind...moreividual healthcare professionals, extended care facilities and alternate site facilities on a global basis. The Company participates in the markets for vascular, urology, oncology and surgical specialty products. It reports its sales in four major product group categories: vascular, urology, oncology and surgical specialties. The Companys vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease (PVD) and heart arrhythmias. These products include: percutaneous transluminal angioplasty, (PTA) catheters, chronic total oc...moreclusion (CTO) catheters, guidewires, fabrics, meshes, introducers and accessories; peripheral vascular stents, covered stents and vascular grafts; vena cava filters; biopsy devices; and electrophysiology products, including electrophysiology laboratory systems and diagnostic, therapeutic and temporary pacing electrode catheters. The Companys urology products include basic drainage products, continence products and urological specialty products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. These include specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters and enteral feeding devices. Its surgical specialty products include implanted grafts and fixation devices for hernia and soft tissue repairs. The companys soft tissue repair products consist of hernia repair grafts, including both synthetic and natural-tissue configurations, and hernia fixation devices. The Company competes in the therapeutic and diagnostic medical device markets around the world. Its products are distributed domestically directly to hospitals and other healthcare institutions as well as through numerous hospitals/surgical supply and other medical specialty distributors with whom the Company has distribution agreements. The Company is subject to various environmental laws and regulations both within and outside the United States.lessless

                  Key People

                  Timothy M. Ring

                  CEO/Chairman of the Board/Director

                  Mr. Christopher S. Holland

                  CFO/Senior VP

                  Bronwen K. Kelly

                  Vice President, Divisional

                  Frank Lupisella,Jr

                  Chief Accounting Officer/Controller/Vice President

                  Sharon M. Alterio

                  Vice President, Divisional

                  • CR Bard Inc

                  • 730 Central Avenue

                  • Murray Hill, NJ 07974

                  • USA.Map

                  • Phone: +1 908 277-8000

                  • Fax: +1 908 277-8412

                  • crbard.com

                  Incorporated

                  1923

                  Employees

                  13,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: